TY - JOUR KW - Adult KW - Aged KW - Bacterial Proteins KW - CD56 Antigen KW - Chaperonin 60 KW - Chaperonins KW - Cytotoxicity, Immunologic KW - Humans KW - Interferon-gamma KW - Interleukin-12 KW - Interleukin-13 KW - Interleukin-18 KW - Killer Cells, Natural KW - leprosy KW - Middle Aged KW - Mycobacterium leprae KW - RNA, Messenger KW - T-Lymphocytes, Cytotoxic AU - De La Barrera S AU - Finiasz M AU - Fink S AU - Ilarregui J AU - Aleman M AU - Olivares L AU - Franco M C AU - Pizzariello G AU - Carmen Sasiain M AB -

Protection against intracellular pathogens such as Mycobacterium leprae is critically dependent on the function of NK cells at early stages of the immune response and on Th1 cells at later stages. In the present report we evaluated the role of IL-18 and IL-13, two cytokines that can influence NK cell activity, in the generation of M. leprae-derived hsp65-cytotoxic T lymphocytes (CTL) from peripheral blood mononuclear cells (PBMC) of leprosy patients. We demonstrated that IL-18 modulates hsp65-induced CTL generation and collaborates with IL-12 for this effect. In paucibacillary (PB) patients and normal controls (N) depletion of NK cells reduces the cytolytic activity. Under these conditions, IL-12 cannot up-regulate this CTL generation, while, in contrast, IL-18 increases the cytotoxic activity both in the presence or absence of NK cells. IL-13 down-regulates the hsp65-induced CTL generation and counteracts the positive effect of IL-18. The negative effect of IL-13 is observed in the early stages of the response, suggesting that this cytokine affects IFNgamma production by NK cells. mRNA coding for IFNgamma is induced by IL-18 and reduced in the presence of IL-13, when PBMC from N or PB patients are stimulated with hsp65. Neutralization of IL-13 in PBMC from multibacillary (MB) leprosy patients induces the production of IFNgamma protein by lymphocytes. A modulatory role on the generation of hsp65 induced CTL is demonstrated for IL-18 and IL-13 and this effect takes place through the production of IFNgamma.

BT - Clinical and experimental immunology C1 - http://www.ncbi.nlm.nih.gov/pubmed/14678270?dopt=Abstract CN - DELA2004 DA - 2004 Jan DO - 10.1111/j.1365-2249.2004.02334.x IS - 1 J2 - Clin. Exp. Immunol. LA - eng N2 -

Protection against intracellular pathogens such as Mycobacterium leprae is critically dependent on the function of NK cells at early stages of the immune response and on Th1 cells at later stages. In the present report we evaluated the role of IL-18 and IL-13, two cytokines that can influence NK cell activity, in the generation of M. leprae-derived hsp65-cytotoxic T lymphocytes (CTL) from peripheral blood mononuclear cells (PBMC) of leprosy patients. We demonstrated that IL-18 modulates hsp65-induced CTL generation and collaborates with IL-12 for this effect. In paucibacillary (PB) patients and normal controls (N) depletion of NK cells reduces the cytolytic activity. Under these conditions, IL-12 cannot up-regulate this CTL generation, while, in contrast, IL-18 increases the cytotoxic activity both in the presence or absence of NK cells. IL-13 down-regulates the hsp65-induced CTL generation and counteracts the positive effect of IL-18. The negative effect of IL-13 is observed in the early stages of the response, suggesting that this cytokine affects IFNgamma production by NK cells. mRNA coding for IFNgamma is induced by IL-18 and reduced in the presence of IL-13, when PBMC from N or PB patients are stimulated with hsp65. Neutralization of IL-13 in PBMC from multibacillary (MB) leprosy patients induces the production of IFNgamma protein by lymphocytes. A modulatory role on the generation of hsp65 induced CTL is demonstrated for IL-18 and IL-13 and this effect takes place through the production of IFNgamma.

PY - 2004 SP - 105 EP - 13 T2 - Clinical and experimental immunology TI - NK cells modulate the cytotoxic activity generated by Mycobacterium leprae-hsp65 in leprosy patients: role of IL-18 and IL-13. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808925/pdf/cei0135-0105.pdf VL - 135 SN - 0009-9104 ER -